Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market
May 2007
Trimethobenzamide SUPPOSITORIES (Tigan) will go off the market...but the oral and injectable forms will stay.
Trimethobenzamide was one of those "unapproved" drugs that came on the market before proof of efficacy was required. Now the FDA is requiring efficacy data...or they will take these drugs off the market.
There's just not enough evidence the suppositories are effective.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote